Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique
Abstract Hyperglycemia and rash are expected but challenging adverse events of phosphatidylinositol-3-kinase inhibition (such as with alpelisib). Two modified Delphi panels were conducted to provide consensus recommendations for managing hyperglycemia and rash in patients taking alpelisib. Experts r...
Hlavní autoři: | , , , , , , , , , , , , , , , , , , , |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Nature Portfolio
2024-01-01
|
Edice: | npj Breast Cancer |
On-line přístup: | https://doi.org/10.1038/s41523-024-00613-x |